Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    Mark Jesus M. Magbanua, John W. Park, editors.
    Contents:
    Circulating tumor cells as cancer biomarkers in the clinic / Ludmilla Thomé Domingos Chinen, Emne Ali Abdallah, Alexcia Camila Braun [and others]
    Strategies for isolation and molecular profiling of circulating tumor cells / Jia-Yang Chen, Ying-Chih Chang
    Aptamer-based methods for detection of circulating tumor cells and their potential for personalized diagnostics / Anna S. Zamay, Galina S. Zamay, Olga S. Kolovskaya, Tatiana N. Zamay [and others]
    Development of a protocol for single-cell analysis of circulating tumor cells in patients with solid tumors / Carolina Reduzzi, Rosita Motta, Giulia Bertolini, Patrizia Miodini, Antonia Martinetti [and others]
    Flow cytometric methods for circulating tumor cell isolation and molecular analysis / Neha Bhagwat, Erica L. Carpenter
    Enrichment and detection of circulating tumor cells and other rare cell populations by microfluidic filtration / Michael Pugia, Mark Jesus M. Magbanua, John W. Park
    Detection and enumeration of circulating tumor cells with invasive phenotype / Haizhen Wang, Xiangwei Wu
    Molecular profiling and significance of circulating tumor cell based genetic signatures / Nisha Kanwar, Susan J. Done
    Detection of gene rearrangements in circulating tumor cells: examples of ALK-, ROS1-, RET-rearrangements in non-small-cell lung cancer and ERG-rearrangements in prostate cancer / Cyril Catelain, Emma Pailler, Marianne Oulhen, Vincent Faugeroux, Anne-Laure Pommier [and others]
    Enrichment, isolation and molecular characterization of EpCAM-negative circulating tumor cells / Rita Lampignano, Helen Schneck, Martin Neumann, Tanja Fehm, Hans Neubauer
    Expression of epithelial mesenchymal transition and cancer stem cell markers in circulating tumor cells / Stefan Werner, Arnulf Stenzl, Klaus Pantel, Tilman Todenh̲fer
    Mesenchymal-epithelial transition and circulating tumor cells in small cell lung cancer / Gerhard Hamilton, Barbara Rath
    Clinical relevance of a candidate stem cell marker, p75 neurotrophin receptor (p75NTR) expression in circulating tumor cells / Tomoyuki Okumura, Tetsuji Yamaguchi, Toru Watanabe, Takuya Nagata, Yutaka Shimada
    Personalized treatment through detection and monitoring of genetic aberrations in single circulating tumor cells / Swee Jin Tan, Trifanny Yeo, Sarvesh Abhay Sukhatme, Say Li Kong, Wan-Teck Lim [and others]
    Glycan markers as potential immunological targets in circulating tumor cells / Denong Wang, Lisa Wu, Xiaohe Liu
    Significance of EGFR expression in circulating tumor cells / María José Serrano, María Jesús Alvarez-Cubero, Diego De Miguel Pérez [and others].
    Digital Access Springer 2017
  • Article
    Sun L, Szafir I.
    Clin Chem. 1977 Sep;23(9):1753-6.
    Patients' sera were analyzed for carbamazepine and ethosuximide by enzyme immunoassay (x) and gas chromatography (y), and the results were compared. The correlation coefficients were: for carbamazepine, x vs. y 0.94 (n = 93); for ethosuximide, x vs. y 0.99 (n = 30). These results suggest that the two methods could be used interchangeably. Ten serum samples supplemented with carbamazepine (2.5 to 12.5 mg/liter) and ethosuximide (20.0 to 130.0 mg/liter) were analyzed by both methods. The correlation coefficients were: x vs. y 0.99 (n = 10) for carbamazepine and x vs. y 0.99 (n =10) for ethosuximide.
    Digital Access Access Options